Roberto P Benzo1, Beatriz Abascal-Bolado2, Megan M Dulohery3. 1. Mindful Breathing Lab, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: benzo.roberto@mayo.edu. 2. Mindful Breathing Lab, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA; Instituto de Investigación Sanitaria Valdecilla, IDIVAL, Santander, Spain. 3. Mindful Breathing Lab, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Abstract
OBJECTIVE: This study aimed to increase our understanding of general self-management (SM) abilities in COPD by determining if SM can predict disease specific quality of life (QoL), by investigating whether specific SM domains are significant in COPD and by exploring the mediating effect of the positive/negative affect in the association between SM and QoL. METHODS: Cross-sectional study based on 292 patients with COPD. Measures included demographics, lung function, gait speed, health care utilization, positive/negative affect, SM abilities, breathlessness and disease specific QoL. We performed, correlation, multiple regression models and mediation analysis (positive/negative affect being mediator between SM and QoL association). RESULTS: After controlling for breathlessness, living alone, marital status, hospitalization history, age and lung function, SM related to QoL (p<0.0001). Investment in behaviors (hobbies and social relationships) and self-efficacy are SM domains independently related to QoL in COPD. Positivity measured by the positive/negative affect ratio completely mediates the relationship of SM with QoL. CONCLUSION: SM is independently associated with disease specific QoL in COPD after adjustment significant covariates but positive/negative affect ratio completely mediates the relationship of SM with QoL. PRACTICE IMPLICATIONS: Measuring positive/negative affect and addressing investment behavior and self-efficacy are important in implementing COPD-SM programs.
OBJECTIVE: This study aimed to increase our understanding of general self-management (SM) abilities in COPD by determining if SM can predict disease specific quality of life (QoL), by investigating whether specific SM domains are significant in COPD and by exploring the mediating effect of the positive/negative affect in the association between SM and QoL. METHODS: Cross-sectional study based on 292 patients with COPD. Measures included demographics, lung function, gait speed, health care utilization, positive/negative affect, SM abilities, breathlessness and disease specific QoL. We performed, correlation, multiple regression models and mediation analysis (positive/negative affect being mediator between SM and QoL association). RESULTS: After controlling for breathlessness, living alone, marital status, hospitalization history, age and lung function, SM related to QoL (p<0.0001). Investment in behaviors (hobbies and social relationships) and self-efficacy are SM domains independently related to QoL in COPD. Positivity measured by the positive/negative affect ratio completely mediates the relationship of SM with QoL. CONCLUSION: SM is independently associated with disease specific QoL in COPD after adjustment significant covariates but positive/negative affect ratio completely mediates the relationship of SM with QoL. PRACTICE IMPLICATIONS: Measuring positive/negative affect and addressing investment behavior and self-efficacy are important in implementing COPD-SM programs.
Authors: Vincent S Fan; Scott D Ramsey; Nicholas D Giardino; Barry J Make; Charles F Emery; Phillip T Diaz; Joshua O Benditt; Zab Mosenifar; Robert McKenna; Jeffrey L Curtis; Alfred P Fishman; Fernando J Martinez Journal: Arch Intern Med Date: 2007-11-26
Authors: Martijn A Spruit; Sally J Singh; Chris Garvey; Richard ZuWallack; Linda Nici; Carolyn Rochester; Kylie Hill; Anne E Holland; Suzanne C Lareau; William D-C Man; Fabio Pitta; Louise Sewell; Jonathan Raskin; Jean Bourbeau; Rebecca Crouch; Frits M E Franssen; Richard Casaburi; Jan H Vercoulen; Ioannis Vogiatzis; Rik Gosselink; Enrico M Clini; Tanja W Effing; François Maltais; Job van der Palen; Thierry Troosters; Daisy J A Janssen; Eileen Collins; Judith Garcia-Aymerich; Dina Brooks; Bonnie F Fahy; Milo A Puhan; Martine Hoogendoorn; Rachel Garrod; Annemie M W J Schols; Brian Carlin; Roberto Benzo; Paula Meek; Mike Morgan; Maureen P M H Rutten-van Mölken; Andrew L Ries; Barry Make; Roger S Goldstein; Claire A Dowson; Jan L Brozek; Claudio F Donner; Emiel F M Wouters Journal: Am J Respir Crit Care Med Date: 2013-10-15 Impact factor: 21.405
Authors: Jane M Cramm; Mathilde M H Strating; Paul L de Vreede; Nardi Steverink; Anna P Nieboer Journal: Health Qual Life Outcomes Date: 2012-01-24 Impact factor: 3.186
Authors: Heidi B Bringsvor; Eva Langeland; Bjørg Frøysland Oftedal; Knut Skaug; Jörg Assmus; Signe Berit Bentsen Journal: Qual Life Res Date: 2019-06-18 Impact factor: 4.147
Authors: Megan K MacGillivray; Mahsa Sadeghi; Patricia B Mills; Jared Adams; Bonita J Sawatzky; W Ben Mortenson Journal: J Spinal Cord Med Date: 2019-05-15 Impact factor: 1.985
Authors: Kelly M Pennington; Roberto P Benzo; Terry D Schneekloth; Marie Budev; Satish Chandrashekaran; David B Erasmus; Erika D Lease; Deborah J Levine; Karin Thompson; Elizabeth Stevens; Paul J Novotny; Cassie C Kennedy Journal: Prog Transplant Date: 2019-12-16 Impact factor: 1.187
Authors: Javier de Miguel-Diez; Ana Lopez-de-Andres; Valentin Herandez-Barrera; Isabel Jimenez-Trujillo; Luis Puente-Maestu; Alicia Cerezo-Lajas; Rodrigo Jimenez-Garcia Journal: Int J Chron Obstruct Pulmon Dis Date: 2018-02-28